Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), bought 11,075 shares at $11.92 ($132K) on 2010-05-10, disclosed to the SEC on 2010-05-12.
Open-market purchase of $132k SGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2019-11-20 | $6.1M | — | Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |